(Q35777126)

English

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso

scientific article published on January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

based on heuristic

inferred from title

0 references

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jörg Kleine-Tebbe

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

object named as

Oliver Pfaar

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

14

object named as

Ludger Klimek

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

4

object named as

Roland Buhl

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Eckard Hamelmann

9

object named as

Eckard Hamelmann

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Christof Ebner

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Peter Eng

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Frank Friedrichs

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Thomas Fuchs

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Doris Hartwig-Bade

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Thomas Hering

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Isidor Huttegger

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Kirsten Jung

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Matthias Volkmar Kopp

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hans Merk

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Uta Rabe

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Joachim Saloga

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Antje Schuster

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Nicolaus Schwerk

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Helmut Sitter

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ulrich Umpfenbach

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Susanne Kaul

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Anja Schwalfenberg

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Claus Bachert

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Peter Schmid-Grendelmeier

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Margitta Worm

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 January 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Allergo journal international

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

282-319

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

https://scigraph.springernature.com/pub.10.1007/s40629-014-0032-2

0 references

Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medici

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Anaphylaxis: still a ghost behind allergen immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sublingual immunotherapy: World Allergy Organization position paper 2013 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Accelerated immunotherapy schedules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

The acute and long-term management of anaphylaxis: protocol for a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Specific immunotherapy-indications and mode of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sublingual immunotherapy for allergic rhinitis and conjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Recombinant allergens: the present and the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

New routes for allergen immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Adjuvants for immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergen-specific immunotherapy and risk of autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Prevalence and socio-economic relevance of allergies in Germany

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

A battery of genotoxicity studies with an allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Immunotherapy for allergic rhinitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Malignancy and specific allergen immunotherapy: the results of a case series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Role of immunmodulators in allergen-specific immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Specific immunotherapy (SIT) in the treatment of allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sublingual immunotherapy for allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Injection allergen immunotherapy for asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Towards evidence-based medicine in specific grass pollen immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Patient's compliance with allergen immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Evidence of adherence to allergen-specific immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Specific immunotherapy with allergen mixes: what is the evidence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Why do doctors and patients not follow guidelines?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

House dust mite control measures for asthma: systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergen specific immunotherapy for atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergen immunotherapy in a patient with human immunodeficiency virus: effect on T-cell activation and viral replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergen injection immunotherapy for seasonal allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sublingual immunotherapy: a comprehensive review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

The oral allergy syndrome: improved diagnostic and treatment methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Treatment of allergic rhinitis during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Minimising the risks of allergen-specific injection immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Specific immunotherapy in asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

12 July 2018

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

[Pharmacoprophylaxis and co-medications in allergen-specific immunotherapy].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

[Recombinant allergens. For routine use or still only science?].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Intralymphatic injections as a new administration route for allergen-specific immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Pharmacoeconomics of subcutaneous allergen immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Rhinitis and onset of asthma: a longitudinal population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Evaluation of near-fatal reactions to allergen immunotherapy injections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Long-term efficacy of preseasonal grass pollen immunotherapy in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Use of omalizumab to improve desensitization safety in allergen immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479478

25 September 2018

Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS40629-014-0032-2

21 January 2018

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

1 reference

https://api.crossref.org/works/10.1007%2FS40629-014-0032-2

21 January 2018

Immunotherapy with cat- and dog-dander extracts

1 reference

https://api.crossref.org/works/10.1007%2FS40629-014-0032-2

21 January 2018

Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1007%2FS40629-014-0032-2

21 January 2018

Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality

1 reference

https://api.crossref.org/works/10.1007%2FS40629-014-0032-2

21 January 2018

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

1 reference

https://api.crossref.org/works/10.1007%2FS40629-014-0032-2

21 January 2018

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

1 reference

https://api.crossref.org/works/10.1007%2FS40629-014-0032-2

21 January 2018

Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The therapy allergens ordinance ("Therapieallergene-Verordnung"). Background and effects]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of allergen-specific immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated immunotherapy schedules and premedication

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous allergen immunotherapy in 3 patients with HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with dog and cat allergen preparations in dog-sensitive and cat-sensitive asthmatics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards for practical allergen-specific immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Specific immunotherapy in allergic asthma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

House dust mite allergy: complete removal of the provoking allergen is a primary therapeutic approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Birch-apple syndrome treated with birch pollen immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of solutions for sublingual immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines for diagnosis and treatment of asthma patients]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Specific immunotherapy in allergic asthma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified forms of allergen immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: a randomized controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aluminium allergy in patients hyposensitized with aluminium-precipitated antigen extracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. A controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Persistence and frequency of prescriptions of subcutaneous allergen-specific immunotherapy (SCIT) prescribed within the German statutory health insurance]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract

1 reference

https://pubmed.ncbi.nlm.nih.gov/26120539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40629-014-0032-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26120539%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35777126&oldid=2055132859"